Fangzhou Lou

1.2k total citations
29 papers, 584 citations indexed

About

Fangzhou Lou is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Fangzhou Lou has authored 29 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 11 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Fangzhou Lou's work include Psoriasis: Treatment and Pathogenesis (6 papers), Immunotherapy and Immune Responses (5 papers) and Immune cells in cancer (4 papers). Fangzhou Lou is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (6 papers), Immunotherapy and Immune Responses (5 papers) and Immune cells in cancer (4 papers). Fangzhou Lou collaborates with scholars based in China, Thailand and United States. Fangzhou Lou's co-authors include Hong Wang, Honglin Wang, Zhenyao Xu, Yang Sun, Jing Bai, Zhaoyuan Liu, Zhikai Wang, Ke Fang, Qianqian Yin and Libo Sun and has published in prestigious journals such as Nature Communications, Immunity and The Journal of Immunology.

In The Last Decade

Fangzhou Lou

26 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangzhou Lou China 13 296 185 178 55 47 29 584
Guiying Wang China 15 388 1.3× 84 0.5× 176 1.0× 135 2.5× 15 0.3× 46 718
Yinglu Li China 15 582 2.0× 42 0.2× 88 0.5× 130 2.4× 4 0.1× 40 858
Jae-Eon Jung South Korea 7 334 1.1× 144 0.8× 54 0.3× 153 2.8× 27 0.6× 9 577
Yingqian Li China 11 292 1.0× 92 0.5× 64 0.4× 37 0.7× 12 0.3× 25 504
Xueting Liu China 15 269 0.9× 219 1.2× 115 0.6× 83 1.5× 6 0.1× 31 611
Andreas Jahnke Germany 10 162 0.5× 208 1.1× 118 0.7× 89 1.6× 80 1.7× 15 527
Kateřina Krejčíková Czechia 12 433 1.5× 150 0.8× 82 0.5× 267 4.9× 13 0.3× 12 743
Litao Yang China 13 494 1.7× 98 0.5× 40 0.2× 52 0.9× 32 0.7× 27 717
Silke Durka Switzerland 11 311 1.1× 125 0.7× 65 0.4× 64 1.2× 34 0.7× 12 597

Countries citing papers authored by Fangzhou Lou

Since Specialization
Citations

This map shows the geographic impact of Fangzhou Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangzhou Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangzhou Lou more than expected).

Fields of papers citing papers by Fangzhou Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangzhou Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangzhou Lou. The network helps show where Fangzhou Lou may publish in the future.

Co-authorship network of co-authors of Fangzhou Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Fangzhou Lou. A scholar is included among the top collaborators of Fangzhou Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangzhou Lou. Fangzhou Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sun, Jiaqi, Yi Xu, Lina Lu, et al.. (2025). Short-Chain Fatty Acids Are Potential Biomarkers of Immune Regulation in Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 66(6). 23–23. 3 indexed citations
3.
Gao, Min, Fangzhou Lou, Yang Sun, et al.. (2025). Loss of MFE-2 impairs microglial lipid homeostasis and drives neuroinflammation in Alzheimer’s pathogenesis. Nature Aging. 5(11). 2279–2296.
4.
Yang, Xiuli, Wenxiang Ding, Fangzhou Lou, et al.. (2025). Nociceptor-derived CGRP enhances dermal type I conventional dendritic cell function to drive autoreactive CD8+ T cell responses in vitiligo. Immunity. 58(8). 2086–2103.e9. 2 indexed citations
5.
Li, Xiangxiao, Fengjiao Zhang, Libo Sun, et al.. (2024). Single-Cell RNA Sequencing Identifies WARS1+ Mesenchymal Stem Cells with Enhanced Immunomodulatory Capacity and Improved Therapeutic Efficacy. The Journal of Immunology. 213(3). 257–267. 1 indexed citations
6.
Sun, Jiaqi, Shuli Chen, Yi Xu, et al.. (2024). Gut microbiota predict retinopathy in patients with diabetes: A longitudinal cohort study. Applied Microbiology and Biotechnology. 108(1). 497–497. 9 indexed citations
7.
Lou, Fangzhou, Hong Zhou, Xiaojie Cai, et al.. (2024). A lncRNA Dleu2-encoded peptide relieves autoimmunity by facilitating Smad3-mediated Treg induction. EMBO Reports. 25(3). 1208–1232. 11 indexed citations
8.
Li, Yan, Xiaojie Cai, Fangzhou Lou, et al.. (2023). CKBA suppresses mast cell activation via ERK signaling pathway in murine atopic dermatitis. European Journal of Immunology. 53(9). e2350374–e2350374. 2 indexed citations
9.
Cai, Xiaojie, Maoying Han, Fangzhou Lou, et al.. (2023). Tenascin C+ papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis. Nature Communications. 14(1). 2004–2004. 32 indexed citations
10.
Wang, Zhikai, Yang Sun, Fangzhou Lou, et al.. (2022). Targeting the transcription factor HES1 by L-menthol restores protein phosphatase 6 in keratinocytes in models of psoriasis. Nature Communications. 13(1). 7815–7815. 19 indexed citations
11.
Cai, Wei, Hong Zhou, Xiangxiao Li, et al.. (2021). Protein phosphatase 6 (Pp6) is crucial for regulatory T cell function and stability in autoimmunity. Genes & Diseases. 9(2). 562–575. 5 indexed citations
12.
Chen, Linjiao, Jing Bai, Danhong Peng, et al.. (2021). SZB120 Exhibits Immunomodulatory Effects by Targeting eIF2α to Suppress Th17 Cell Differentiation. The Journal of Immunology. 206(5). 953–962. 5 indexed citations
13.
Peng, Danhong, Linjiao Chen, Yang Sun, et al.. (2020). Melanoma suppression by quercein is correlated with RIG-I and type I interferon signaling. Biomedicine & Pharmacotherapy. 125. 109984–109984. 31 indexed citations
14.
Niu, Liman, Fangzhou Lou, Yang Sun, et al.. (2020). A micropeptide encoded by lncRNA MIR155HG suppresses autoimmune inflammation via modulating antigen presentation. Science Advances. 6(21). eaaz2059–eaaz2059. 144 indexed citations
15.
Lou, Fangzhou, Yang Sun, & Honglin Wang. (2020). Protocol for Flow Cytometric Detection of Immune Cell Infiltration in the Epidermis and Dermis of a Psoriasis Mouse Model. STAR Protocols. 1(3). 100115–100115. 20 indexed citations
16.
Lou, Fangzhou, et al.. (2019). LB1046 Keratinocyte metabolic reprogramming promotes self-RNA sensation by dendritic cells in psoriasis. Journal of Investigative Dermatology. 139(9). B2–B2. 1 indexed citations
17.
Fang, Ke, Lingyun Zhang, Zhaoyuan Liu, et al.. (2016). Soluble Tumor Necrosis Factor Receptor 1 Released by Skin-Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation. Stem Cells Translational Medicine. 5(3). 301–313. 29 indexed citations
18.
Li, Qun, Weihong Sun, Jianyang Ma, et al.. (2016). miRNA-27b modulates endothelial cell angiogenesis by directly targeting Naa15 in atherogenesis. Atherosclerosis. 254. 184–192. 17 indexed citations
19.
Zhang, Lingyun, Ke Fang, Zhaoyuan Liu, et al.. (2015). MicroRNA-31 negatively regulates peripherally derived regulatory T-cell generation by repressing retinoic acid-inducible protein 3. Nature Communications. 6(1). 7639–7639. 76 indexed citations
20.
Lou, Fangzhou, et al.. (2003). Effects of Moclobemide on Event-related Potentials of Depressed Patients — a Preliminary Study. Hong Kong journal of psychiatry. 13(1). 2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026